Phase 1 safety and immunogenicity data in individuals who received a third dose of the Pfizer-BioNTech vaccine (BNT162b2) show a favorable safety profile and robust […]
….. for Emergency Use Authorization of Novavax’ Recombinant Nanoparticle COVID-19 Vaccine – Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller […]
Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series Six-fold increase in cross-reactive functional antibodies […]
and Manufacturing Facility in Gaithersburg, Maryland The acquisition strengthens BioNTech’s cell therapy pipeline by accelerating the individualized solid tumor Neoantigen TCR cell therapy research and […]
Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) […]
BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Kite, a Gilead Company (Nasdaq: GILD, “Kite”) today announced the two companies have entered into a purchase agreement for […]
ESA Satellite-enabled drones have accelerated the provision of life-saving medical supplies at NHS hospitals in Scotland, boosting the country’s efforts to combat COVID-19. The fleet […]
On May 17, 2021, the European Medicines Agency (EMA) has approved a change to the existing storage conditions. The thawed, undiluted COVID-19 vaccine can be […]
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a Biologics License Application (BLA) with the U.S. Food and Drug […]
The technology used in some Covid-19 doses could facilitate different vaccines or treatments for certain cancers. These advances need the firm and constant support of […]
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY® PDF Version European Union exercises option under previous agreement to […]
Merck, a leading science and technology company, today announced an investment of EUR 20 million to expand research and development and manufacturing capabilities at its […]
Copyright © 2021 | WordPress Theme by MH Themes
